Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease
- 29 July 2005
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 113 (2) , 205-218
- https://doi.org/10.1007/s00702-005-0312-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patientsEuropean Journal of Neurology, 2004
- Orbital and Dorsolateral Frontal Perfusion Defect Associated With Behavioral Response to Cholinesterase Inhibitor Therapy in Alzheimer's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2000
- Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1999
- How to Estimate Global Activity Independent of Changes in Local ActivityNeuroImage, 1997
- Implementation and Validation of a Fully Automatic System for Intra- and Interindividual Registration of PET Brain ScansJournal of Computer Assisted Tomography, 1997
- Episodic memory functioning in a community-based sample of old adults with major depression: Utilization of cognitive support.Journal of Abnormal Psychology, 1994
- A Computerized Brain AtlasJournal of Computer Assisted Tomography, 1991
- Comparative Regional Analysis of 2-Fluorodeoxyglucose and Methylglucose Uptake in Brain of Four Stroke Patients. With Special Reference to the Regional Estimation of the Lumped ConstantJournal of Cerebral Blood Flow & Metabolism, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Higher Cortical Functions in ManThe American Journal of Psychology, 1968